Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 849

1.

Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.

Navon-Venezia S, Ben-Ami R, Carmeli Y.

Curr Opin Infect Dis. 2005 Aug;18(4):306-13. Review.

PMID:
15985826
2.
3.

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.

Zavascki AP, Carvalhaes CG, Picão RC, Gales AC.

Expert Rev Anti Infect Ther. 2010 Jan;8(1):71-93. doi: 10.1586/eri.09.108. Review.

PMID:
20014903
4.
5.

Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

McGowan JE Jr.

Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70. Review.

PMID:
16735148
6.

[Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].

Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.

Mikrobiyol Bul. 2008 Apr;42(2):321-9. Turkish.

PMID:
18697430
7.
9.

"Future" threat of gram-negative resistance in Singapore.

Tan TT.

Ann Acad Med Singapore. 2008 Oct;37(10):884-90. Review.

10.

Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.

Kunz AN, Brook I.

Chemotherapy. 2010;56(6):492-500. doi: 10.1159/000321018. Epub 2010 Nov 24. Review.

PMID:
21099222
12.

Acinetobacter baumannii: an emerging multidrug-resistant threat.

Gootz TD, Marra A.

Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309. Review.

PMID:
18588496
13.

[Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].

Taşbakan MS, Pullukçu H, Ekren PK, Oz AT, Midilli M, Aydemir S, Gürgün A, Başoğlu OK, Bacakoğlu F.

Mikrobiyol Bul. 2009 Jan;43(1):61-70. Turkish.

PMID:
19334381
14.

Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.

Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S.

Arch Intern Med. 2002 Jul 8;162(13):1515-20.

PMID:
12090889
15.

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

Kwa AL, Loh C, Low JG, Kurup A, Tam VH.

Clin Infect Dis. 2005 Sep 1;41(5):754-7. Epub 2005 Jul 20.

PMID:
16080101
16.

Treatment options for multidrug-resistant nonfermenters.

Briceño DF, Quinn JP, Villegas MV.

Expert Rev Anti Infect Ther. 2010 Mar;8(3):303-15. doi: 10.1586/eri.09.125. Review.

PMID:
20192684
17.

Treatment of Acinetobacter infections.

Michalopoulos A, Falagas ME.

Expert Opin Pharmacother. 2010 Apr;11(5):779-88. doi: 10.1517/14656561003596350. Review.

PMID:
20210684
18.

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.

Kempf M, Rolain JM.

Int J Antimicrob Agents. 2012 Feb;39(2):105-14. doi: 10.1016/j.ijantimicag.2011.10.004. Epub 2011 Nov 22. Review.

PMID:
22113193
19.
20.

[Aerosolized colistin in the treatment of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa pneunomia].

Peral Sánchez D, Armero Ibáñez R, Seller Losada JM, Solaz Roldán C.

Med Clin (Barc). 2007 Sep 22;129(10):397. Spanish. No abstract available.

PMID:
17915139

Supplemental Content

Support Center